{"name":"Estetra","slug":"estetra","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VAL","genericName":"VAL","slug":"val","indication":"Cytomegalovirus (CMV) retinitis in immunocompromised patients (including HIV/AIDS)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Estetrol oral tablet","genericName":"Estetrol oral tablet","slug":"estetrol-oral-tablet","indication":"Oral contraception","status":"phase_3"}]}],"pipeline":[{"name":"VAL","genericName":"VAL","slug":"val","phase":"marketed","mechanism":"VAL is a valganciclovir prodrug that is converted to ganciclovir in the body to inhibit viral DNA polymerase and prevent cytomegalovirus (CMV) replication.","indications":["Cytomegalovirus (CMV) retinitis in immunocompromised patients (including HIV/AIDS)","CMV disease prevention in high-risk transplant recipients"],"catalyst":""},{"name":"Estetrol oral tablet","genericName":"Estetrol oral tablet","slug":"estetrol-oral-tablet","phase":"phase_3","mechanism":"Estetrol is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors to provide estrogenic activity with a potentially improved safety profile.","indications":["Oral contraception","Hormone replacement therapy in menopausal women"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQVFNPLXFFTDdCZ2liLXZNRDJFVXp5Y29yRXVpYkFtNDcxTXpzUXJjQWwwYkpUZ1ZRYktZWHFQSFdrZ3U2VC1pNWNkc0dROXljUXI2WVh2M0ptUWFxVzhLaVB5dUNEZ25OYktidlhLTUVaX0l5dGdkLVN5MjE5NTZCYXpVV2R4eEcyYmNLRA?oc=5","date":"2024-09-25","type":"regulatory","source":"Hungary Today","summary":"Richter’s Female Health Product to Be Marketed in Japan - Hungary Today","headline":"Richter’s Female Health Product to Be Marketed in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPbmFPNlB4b1lPOXpkV1NZVkRMUDVOR2xGakZaYWxreDNfemN0b1VNV3E4TnplWFVhdzdFaGRlUE9VZmtIRDVsNWhObkRyUEZKbHFoNksxd2E2emtzTkpPeDNyRkpUa01ISl9ySXRLRDNlSDNrVXQ4blFrdklrcUhnZHI4dHZ6ZXJCamIzWjNJWFUyS3ZUaXJmaHpkT0Y1eTdqSUVoa0E2aw?oc=5","date":"2024-06-12","type":"regulatory","source":"Pharmaceutical Technology","summary":"Bankrupt Mithra cashes in on remaining assets for $188.2m - Pharmaceutical Technology","headline":"Bankrupt Mithra cashes in on remaining assets for $188.2m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQdU9iRm8zMTRQbzRUaDZzemxRSHA0bXZHQU5OTHR2OEdrZE1nRHdlVmxBMVJ4RmVEa19nX3E0MWN3TzVzVE15bjlRXzBuSXd5cVhQeDJxVzZNSWJuR0R3QXF2eG4taEMzZjJiVWdvcmZBM2hQbEdTVUdzMmtFNkJRYXZoeXYzUzc5WFpvWFpNUEU2V0RlZm1Pb05QNFlZVmY3cmV5VWRR?oc=5","date":"2024-03-05","type":"pipeline","source":"The Brussels Times","summary":"Belgian pharmaceutical company Mithra fires CEO - The Brussels Times","headline":"Belgian pharmaceutical company Mithra fires CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOemF2X01aMzhfaHZNZ1RfTzB2Zlh6alQxZ0dITHN3aVQ1NElRcEpyZEhxaTd1eWlZY09QRURNZ1FXR3o0ZHE4bWk5NEw5X2RwWnZJZVpWbENkcHY0c1VJZlBnU21pNTNscDl6NU9UUzhIX0k0YlNYNGZLUGswUWVMR0R1YnVFLVJtdkxWT0Ria1c?oc=5","date":"2024-02-28","type":"pipeline","source":"Yahoo Finance","summary":"Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies - Estetra, Bayer, Hansoh BioMedical R&D Company, Mitsubishi Tanabe Pharma, Astel","headline":"Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNQ00zT2NhMWpYck1xYUJXRy13ck5scFA4ZjFHRFBkM2tVR29vNnY4ZldFV2xsX0FTNVQ1czBaLTd2cm82NlpfcmlUdlp6QXVhZDJmazhwSEZ2VE4yWHA2U1lubkpLOHZ3aFNqUUdrcTdqSnI3WUhkSlpnd0NLRDhJSXRCS3FWdWtQUmhnN2VOS2dmd2w3VlY5bi1yajF3QXNQR0F3d2ttelNaVGwzaXVRTHVVbw?oc=5","date":"2020-12-23","type":"deal","source":"BBJ - Budapest Business Journal","summary":"Richter, Mithra sign deal to sell new oral contraceptive in Latin America - BBJ - Budapest Business Journal","headline":"Richter, Mithra sign deal to sell new oral contraceptive in Latin America - BBJ","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}